Please login to the form below

Not currently logged in
Email:
Password:

Clinical

Ionis says rare disease drug works, but safety concerns linger

Ionis says rare disease drug works, but safety concerns linger

Inotersen has been linked to cases of thrombocytopenia

Biogen hands out $120m upfront for Remedy stroke drug

Biogen hands out $120m upfront for Remedy stroke drug

Cirara vying to be first new treatment since the 1990s

Tecentriq bladder cancer approval in doubt after trial failure

Tecentriq bladder cancer approval in doubt after trial failure

The PD-L1 inhibitor failed to extend overall survival in a phase III study

AZ buoyed by Imfinzi lung cancer trial

AZ buoyed by Imfinzi lung cancer trial

Phase III trial showed PD-L1 inhibitor Imfinzi increased progression-free survival

Lilly set to head to regulators with CGRP migraine drug

Lilly set to head to regulators with CGRP migraine drug

Gathers three positive late-stage trials of galcanezumab as it chases Amgen

More clinical news articles

Japanese pharma pulls no punches with post-Brexit UK

Japanese pharma pulls no punches with post-Brexit UK

Japanese companies want  reassurance from the UK on its future in science and innovation

Brexit: the facts (and the alternative facts)

Brexit: the facts (and the alternative facts)

How Brexit affects pharma

Brexit: Implications for the pharma industry

Brexit: Implications for the pharma industry

The aftermath of Brexit

Can UK pharma rise to the post-Brexit challenge?

Can UK pharma rise to the post-Brexit challenge?

Our dominant and thriving industry is one we should be proud of

Real-world evidence

Real-world evidence Investigating the sources of evidence as best practice moves from being knowledge-based to evidence-based

More clinical features

Featured jobs

Subscribe to our email news alerts

Latest intelligence

Digital storytelling means building the story around data
The value of digital storytelling in pharma lies in its ability to convert facts and figures into compelling content for patients and HCPs....
Pharma and free medicines: a different perspective
Pfizer have recently announced that they will provide the breast cancer drug, palbociclib, free of charge to patients....
arrow
The false economy of following the leader
How can companies in the sector shake things up?...

Infographics